JP2022543320A5 - - Google Patents
Info
- Publication number
- JP2022543320A5 JP2022543320A5 JP2022507761A JP2022507761A JP2022543320A5 JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5 JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022507761 A JP2022507761 A JP 2022507761A JP 2022543320 A5 JP2022543320 A5 JP 2022543320A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- complex according
- complex
- peptide carrier
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1911403.2 | 2019-08-09 | ||
| GBGB1911403.2A GB201911403D0 (en) | 2019-08-09 | 2019-08-09 | Conjugate and uses thereof |
| PCT/GB2020/051891 WO2021028666A1 (en) | 2019-08-09 | 2020-08-07 | Conjugate and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543320A JP2022543320A (ja) | 2022-10-11 |
| JP2022543320A5 true JP2022543320A5 (cg-RX-API-DMAC7.html) | 2023-08-14 |
| JP7678654B2 JP7678654B2 (ja) | 2025-05-16 |
Family
ID=67990936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507761A Active JP7678654B2 (ja) | 2019-08-09 | 2020-08-07 | 複合体及びその使用 |
Country Status (13)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018150196A1 (en) | 2017-02-17 | 2018-08-23 | Oxford University Innovation Limited | Cell penetrating peptides modified by glycosylation |
| GB201812972D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| GB201812980D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| AU2019394177A1 (en) * | 2018-12-07 | 2021-06-10 | Oxford University Innovation Limited | Linkers |
| CA3211038A1 (en) | 2021-02-12 | 2022-08-18 | Oxford University Innovation Limited | Cell-penetrating peptide conjugates and methods of their use |
| US20240189434A1 (en) * | 2021-03-12 | 2024-06-13 | Pepgen Inc. | Methods of treating myotonic dystrophy type 1 using peptide-oligonucleotide conjugates |
| IL321025A (en) * | 2022-11-21 | 2025-07-01 | Pepgen Inc | Cell-penetrating peptides, conjugates thereof, and methods of their use |
| EP4759826A1 (en) * | 2023-08-07 | 2026-06-17 | Toagosei Co., Ltd. | Peptide fragment and use thereof |
| WO2025033255A1 (ja) * | 2023-08-07 | 2025-02-13 | 東亞合成株式会社 | ペプチドフラグメント及びその利用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6047270B2 (ja) * | 2006-08-11 | 2016-12-21 | バイオマリン テクノロジーズ ベー.フェー. | Dnaリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段 |
| CA2691673A1 (en) | 2007-06-29 | 2009-01-08 | Avi Biopharma, Inc. | Tissue specific peptide conjugates and methods |
| US20100016215A1 (en) * | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| WO2009147368A1 (en) * | 2008-06-04 | 2009-12-10 | Medical Research Council | Peptides |
| US20110269665A1 (en) * | 2009-06-26 | 2011-11-03 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
| WO2013030569A2 (en) * | 2011-08-30 | 2013-03-07 | Michael John Gait | Peptides |
| US10111962B2 (en) | 2012-09-25 | 2018-10-30 | Genzyme Corporation | Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy |
| RU2708237C2 (ru) | 2014-08-22 | 2019-12-05 | Общество с ограниченной ответственностью "НооГен" | Модифицированные олигонуклеотиды и способ их получения |
-
2019
- 2019-08-09 GB GBGB1911403.2A patent/GB201911403D0/en not_active Ceased
-
2020
- 2020-08-07 KR KR1020227007655A patent/KR20220079524A/ko active Pending
- 2020-08-07 AU AU2020327659A patent/AU2020327659A1/en active Pending
- 2020-08-07 CN CN202080071067.8A patent/CN114615998B/zh active Active
- 2020-08-07 JP JP2022507761A patent/JP7678654B2/ja active Active
- 2020-08-07 BR BR112022002309A patent/BR112022002309A2/pt unknown
- 2020-08-07 CA CA3149700A patent/CA3149700A1/en active Pending
- 2020-08-07 CN CN202510582562.XA patent/CN120837670A/zh active Pending
- 2020-08-07 MX MX2022001712A patent/MX2022001712A/es unknown
- 2020-08-07 US US17/631,654 patent/US20220275372A1/en active Pending
- 2020-08-07 EP EP20754817.3A patent/EP4010030A1/en active Pending
- 2020-08-07 WO PCT/GB2020/051891 patent/WO2021028666A1/en not_active Ceased
-
2022
- 2022-02-07 IL IL290424A patent/IL290424A/en unknown
- 2022-02-08 SA SA522431627A patent/SA522431627B1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534131A5 (cg-RX-API-DMAC7.html) | ||
| US8609065B2 (en) | Molecules for targeting compounds to various selected organs, tissues or tumor cells | |
| CA2846218C (en) | Cell-penetrating peptides having a central hydrophobic domain | |
| US20220090066A1 (en) | Cell penetrating molecule | |
| JP4974890B2 (ja) | ペプチドが結合された、イノシン置換アンチセンスオリゴマー化合物および方法 | |
| Tung et al. | Preparation and applications of peptide− oligonucleotide conjugates | |
| JP7678654B2 (ja) | 複合体及びその使用 | |
| WO2023026994A1 (ja) | ヒトトランスフェリンレセプター結合ペプチド-薬物コンジュゲート | |
| JP7846169B2 (ja) | 細胞透過性ペプチド | |
| WO1997012912A1 (fr) | Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives | |
| JP2025508337A5 (cg-RX-API-DMAC7.html) | ||
| GB2563964A (en) | Cell penetrating peptides | |
| RU2022105559A (ru) | Конъгат и его применения | |
| WO2001027261A2 (en) | Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino | |
| US20230399378A1 (en) | Peptide-based delivery of agents | |
| ES2465569T3 (es) | Proteína de fusión de melusina recombinante como agente farmacológico en el tratamiento de patologías cardiacas y composiciones de la misma | |
| RU2025116420A (ru) | Проникающие в клетку пептиды, их конъюгаты и способы их применения | |
| HK40075520B (en) | Conjugate and uses thereof | |
| US20210024583A1 (en) | Compositions and methods for peptide mediated oligonucleotide delivery to the central nervous system | |
| WO2025229308A1 (en) | Conjugate for treating repeat expansion disorders | |
| RU2023123089A (ru) | Проникающие в клетки пептидные конъюгаты | |
| HK40075520A (zh) | 缀合物及其用途 | |
| RU2021105152A (ru) | Проникающие в клетку пептиды | |
| NZ582522A (en) | A conjugate comprsing the amino acid sequence LPWKPLG for targeting compounds to brain cells, neuronal cells or tumour cells of neuronal or neuroectodermal origin | |
| Wei | Design, synthesis and properties of polyarginine-oligonucleotide conjugates and polyarginine-bridged oligonucleotide pairs |